OTCMKTS:LHDXQ

Lucira Health (LHDXQ) Stock Forecast, Price & News

$0.0002

0.00 (0.00%)

(As of 09/21/2023 ET)

Compare

Today's Range: $0.0002
▼
$0.0002
50-Day Range: N/A
52-Week Range: $0.00
▼
$1.45

Volume: 43 shs
Average Volume: 6,802 shs
Market Capitalization: $8,120.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Lucira Health (OTCMKTS:LHDXQ) Stock

Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California. On February 22, 2023, Lucira Health, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

LHDXQ Price History

30 days | 90 days | 365 days | Advanced Chart

LHDXQ Stock News Headlines

September 20, 2023 | msn.com

U.S. govt. to restart program to ship free at-home COVID tests

August 3, 2023 | forbes.com

Best Senior Dating Sites Of 2023

September 22, 2023 | Chaikin Analytics (Ad)

This is the #1 Stock to Buy for the AI Tidal Wave

Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.

April 28, 2023 | benzinga.com

Remember Lucira Health's 30 Minute Home Test Kit? Pfizer Just Bought the Bankrupt Company Via Winning Auction Bid

April 20, 2023 | marketwatch.com

8-K: Lucira Health, Inc.

April 11, 2023 | bizjournals.com

Bankruptcy court bidder for Covid-flu test maker Lucira objects to planned sale to Pfizer

April 7, 2023 | bizjournals.com

Pfizer to buy Covid-flu test developer Lucira Health out of bankruptcy court

April 6, 2023 | wsj.com

Firm Retention Summary: Lucira Health Inc.

September 22, 2023 | Chaikin Analytics (Ad)

This is the #1 Stock to Buy for the AI Tidal Wave

Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.

March 29, 2023 | marketwatch.com

Lucira Health Announces U.S. Launch of First & Only At-Home Combination COVID-19 & Flu Test Amidst Sale Process

March 20, 2023 | investing.com

Lucira Health Inc (LHDXQ)

March 18, 2023 | finance.yahoo.com

FDA Addresses 'Misinformation' Concerning Delayed Approval Of Lucira Health's COVID-19 & Flu Home Test

March 17, 2023 | seekingalpha.com

LHDXQ Lucira Health, Inc.

March 10, 2023 | finance.yahoo.com

FDA Addresses 'Misinformation' Concerning Delayed Approval Of Lucira Health's COVID-19 & Flu Home Test

March 8, 2023 | bizjournals.com

Covid-flu test fell short of number of flu samples, FDA says in explaining delay

March 8, 2023 | bizjournals.com

FDA fires back at claims of long delay in approving combined Covid-flu test

March 7, 2023 | finance.yahoo.com

UPDATE 1-Lucira's home test for flu and COVID-19 gets U.S. FDA nod for OTC use

March 7, 2023 | finance.yahoo.com

FDA Approval Brings Some Good News For Bankrupt Lucira Health

March 3, 2023 | investorplace.com

Why Is Lucira Health (LHDX) Stock Down 14% Today?

February 28, 2023 | benzinga.com

Short Volatility Alert: Lucira Health Inc

February 28, 2023 | msn.com

Lucira Soars on FDA Approval of COVID-19 and Flu Test

February 27, 2023 | finance.yahoo.com

Lucira Health Announces FDA Authorization of First & Only At-Home Combination Covid-19 & Flu Test and Comments on Chapter 11 Bankruptcy Filing

February 27, 2023 | msn.com

Lucira Health is Soaring Monday: Here Are The Details

February 27, 2023 | rttnews.com

FDA Authorizes First At-Home Test To Detect Flu And COVID-19

February 24, 2023 | bizjournals.com

Delay with Covid-flu test sent East Bay company to Chapter 11. Regulators OK it — two days later

February 24, 2023 | finance.yahoo.com

Lucira stock more than doubles after hours on FDA OK for COVID-19, flu test

February 24, 2023 | seekingalpha.com

Lucira Health to sell business and file Chapter 11 bankruptcy; shares down 7%

See More Headlines

Receive LHDXQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lucira Health and its competitors with MarketBeat's FREE daily newsletter.

LHDXQ Company Calendar

Last Earnings: 11/11/2021
Today: 9/22/2023
Next Earnings (Estimated): 10/02/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Medical Devices
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:LHDXQ
CUSIP: N/A
CIK: 1652724
Web: www.lucirahealth.com
Phone: 510-350-8071
Fax: N/A
Employees: 221
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $93.06 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $4.81 per share
Price / Book: 0.00

Miscellaneous

Outstanding Shares: 40,600,000
Free Float: 28,257,000
Market Cap: $8,120.00
Optionable: Optionable
Beta: 2.39

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

Greg Chodaczek
Investor Relations

Dr. Nadine Greiner Ph.D.
Chief HR Officer

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

LHDXQ Stock - Frequently Asked Questions

How have LHDXQ shares performed in 2023?: Lucira Health's stock was trading at $0.5490 at the beginning of 2023. Since then, LHDXQ shares have decreased by 100.0% and is now trading at $0.0002.
View the best growth stocks for 2023 here.
When is Lucira Health's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, October 2nd 2023.
View our LHDXQ earnings forecast.
How were Lucira Health's earnings last quarter?: Lucira Health, Inc. (OTCMKTS:LHDXQ) posted its quarterly earnings data on Thursday, November, 11th. The company reported ($0.47) EPS for the quarter, topping analysts' consensus estimates of ($0.51) by $0.04. The business earned $14.98 million during the quarter, compared to analyst estimates of $18 million.
What is Lucira Health's stock symbol?: Lucira Health trades on the OTCMKTS under the ticker symbol "LHDXQ."

How do I buy shares of Lucira Health?: Shares of LHDXQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Lucira Health's stock price today?: One share of LHDXQ stock can currently be purchased for approximately $0.00.
How much money does Lucira Health make?: Lucira Health (OTCMKTS:LHDXQ) has a market capitalization of $8,120.00 and generates $93.06 million in revenue each year. The company earns $-64,830,000.00 in net income (profit) each year or ($3.58) on an earnings per share basis.
How many employees does Lucira Health have?: The company employs 221 workers across the globe.
How can I contact Lucira Health?: Lucira Health's mailing address is 1412 62ND STREET, EMERYVILLE CA, 94608. The official website for the company is www.lucirahealth.com. The company can be reached via phone at 510-350-8071.

This page (OTCMKTS:LHDXQ) was last updated on 9/22/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial